Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2021-09-13 00:00:00 ET · period of report 2021-09-13 · accession 0001209191-21-055783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-13 | 2021-09-13 | RLAY | Catinazzo Thomas | SVP, Fin | M - OptEx | $4.12 | +22.5K | 38.1K | +144% | +$92.7K |
| D | 2021-09-13 | 2021-09-13 | RLAY | Catinazzo Thomas | SVP, Fin | S - Sale+OE | $35.00 | -22.5K | 15.6K | -59% | -$787.5K |
| D | 2021-09-13 | 2021-09-13 | RLAY | Catinazzo Thomas | SVP, Fin | M - OptEx | $0.00 | -22.5K | 62.0K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-13 | M | A | 22,500 | $4.12 | 38,077 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-13 | S | D | 22,500 | $35.00 | 15,577 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-13 | M | D | 22,500 | $0.00 | 62,043 | D | $4.12 · — to 2028-04-09 | 22,500 Common Stock | (F2) Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. |